{
    "organizations": [],
    "uuid": "9e0cad6496a4dfca4160242f875a6cacf90576b5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-titan-pharmaceuticals-q1-loss-per/brief-titan-pharmaceuticals-q1-loss-per-share-0-12-idUSASC0A2FX",
    "ord_in_thread": 0,
    "title": "BRIEF-Titan Pharmaceuticals Q1 Loss Per Share $0.12",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Titan Pharmaceuticals Inc:\n* TITAN PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 REVENUE $1.1 MILLION * TITAN PHARMACEUTICALS - BELIEVES CO HAS SUFFICIENT CASH AS AT MARCH 31, 2018 TO FUND PLANNED OPERATIONS INTO Q3 OF 2018 Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T04:20:00.000+03:00",
    "crawled": "2018-05-16T18:54:46.054+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "titan",
        "pharmaceutical",
        "inc",
        "titan",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "revenue",
        "million",
        "titan",
        "pharmaceutical",
        "belief",
        "co",
        "sufficient",
        "cash",
        "march",
        "fund",
        "planned",
        "operation",
        "q3",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}